anewmeds.com (WENA) Narx-foyda multiplikatori
Demensiya va Parkinson kasalligiga qarshi kurashish uchun innovatsion gen terapiyasi usullarini ishlab chiqish Anew Medical, Inc. (WENA) kompaniyasi uchun daromad keltirmoqda, garchi FDA ning qat'iy nazorati va patent cheklovlari sezilarli to'siqlarni yaratayotgan bo'lsa-da. GURU.Markets platformasida aktivning bozor qiymati dinamikasi -77.80 darajasida bo'lib, bu investitsiya qiziqishini tasdiqlaydi. Shu bilan birga, R&D laboratoriyalari va hamkor ishlab chiqarish korxonalari uzilishlarsiz ishlamoqda hamda uskunalarning to'liq operatsion tayyorgarligini saqlab qolmoqda.
Anew Medical, Inc. kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Barcha qarzlarning o‘z mablag‘lariga nisbati Anew Medical, Inc.|WENA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Anew Medical|WENA - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Anew Medical Inc.|WENA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzdorligi Anew Medical|Oraliq qoplama koeffitsiyenti anewmeds.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
WENA - Sof foyda|Kelajakdagi foyda Anew Medical, Inc.|WENA - P/E multiplikatori|Forvard P/E multiplikatori anewmeds.com|WENA - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Anew Medical, Inc.|WENA - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Anew Medical|WENA - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi anewmeds.com|WENA - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Anew Medical, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahlili:WENA (Anew Medical, Inc.)
P/E koeffitsiyenti aksiyaning bozor qiymatini biznesning sof foydasi bilan solishtirish orqali investitsiyalarning qoplanish muddatini belgilaydi. Jori P/E koeffitsiyentini tahlil qilish orqali investor spekulyativ shovqinni aktivning fundamental qiymatidan ajratadi. Ushbu metrika narxning EPS ga nisbati sifatida hisoblanadi va kelajakdagi pul oqimlari bo'yicha bozor kutganlarini aks ettiradi. Anew Medical, Inc. (WENA) uchun ushbu ko'rsatkich Klotho protein terapiyasi istiqbollarining qiymatini baholaydi. Ushbu hisob-kitob Parkinson kasalligi va ALS uchun davolash vositalarini ishlab chiqish qanchalik hadda haddan tashqari baholanganini aniqlashga yordam beradi.
Muhim raqobatchilar
Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OVID|Acumen Pharmaceuticals Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati CervoMed Inc|ATHE: P/E multiplikatori|Narx-foyda koeffitsiyenti Clene Nanomedicine|Narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Kapitalizatsiyaning foydaga nisbati|gracetx.com - Narx-foyda koeffitsiyenti|AIFF: Narx-foyda multiplikatori|Klotho Neurosciences - P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narx-foyda multiplikatori|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati NeurAxis, Inc|Narxning foydaga nisbati HSDT|P/E multiplikatori PASG|Biznesning o‘zini qoplash muddati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Narx-foyda koeffitsiyenti|P/E multiplikatori Athira ATHA|Addex Therapeutics - P/E multiplikatori|ALZN - P/E multiplikatori|Cyclerion (CYCN) - Narxning foydaga nisbati|Protagenic (PTIX) - P/E multiplikatori|Narxning foydaga nisbati Pasithea|Narx-foyda multiplikatori CRGT (Cortigent)|Narxning foydaga nisbati Avenue Therapeutics (ATXI)|BCLI - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori CARA (Cara Therapeutics Inc)|CHRO - Narx-foyda koeffitsiyenti|ELYM: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Narxning foydaga nisbati|Marinus - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati NKGen Biotech Inc|NRBO: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SAGE (Sage Therapeutics, Inc.)|Biznesning o‘zini qoplash muddati Neurotrope|Narxning foydaga nisbati Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Kapitalizatsiyaning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori
